Optima Medical Innovations Corp.
TOKIF
$0.00
$0.000.00%
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Revenue | -72.87% | -74.03% | -4.83% | 0.87% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -72.87% | -74.03% | -4.83% | 0.87% | -- |
| Cost of Revenue | -70.37% | -72.39% | 2.92% | 7.28% | -- |
| Gross Profit | -79.65% | -78.18% | -21.53% | -11.52% | -- |
| SG&A Expenses | -107.03% | -103.34% | -59.56% | -58.56% | -- |
| Depreciation & Amortization | -34.21% | -39.85% | -45.06% | -44.76% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -86.91% | -87.47% | -38.66% | -38.63% | -- |
| Operating Income | 106.91% | 102.60% | 68.21% | 65.71% | -- |
| Income Before Tax | 97.81% | 97.42% | 78.55% | 75.64% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 97.81% | 97.42% | 78.55% | 75.64% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 97.81% | 97.42% | 78.55% | 75.64% | -- |
| EBIT | 106.91% | 102.60% | 68.21% | 65.71% | -- |
| EBITDA | 119.27% | 112.30% | 72.40% | 70.25% | -- |
| EPS Basic | 98.05% | 97.71% | 80.57% | 77.72% | -- |
| Normalized Basic EPS | 101.80% | 99.72% | 52.58% | 49.90% | -- |
| EPS Diluted | 98.05% | 97.71% | 80.57% | 77.72% | -- |
| Normalized Diluted EPS | 101.80% | 99.72% | 52.58% | 49.90% | -- |
| Average Basic Shares Outstanding | 7.55% | 11.06% | 13.59% | 12.52% | -- |
| Average Diluted Shares Outstanding | 7.55% | 11.06% | 13.59% | 12.52% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
